|
27 May 2020 |
Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb
|
|
26 May 2020 |
Tetra Therapeutics Enters Into Definitive Merger Agreement To Be Acquired by Shionogi
|
|
26 May 2020 |
Merck to Acquire Themis
|
|
26 May 2020 |
Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801
|
|
25 May 2020 |
Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets
|
|
23 May 2020 |
AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly
|
|
20 May 2020 |
Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
|
|
19 May 2020 |
Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
|
|
18 May 2020 |
OSE Immunotherapeutics Presents CLEC-1, Novel Myeloid Immune Checkpoint Target for Cancer Immunotherapy
|
|
16 May 2020 |
LegoChem Biosciences and Iksuda Enter Licensing Agreement for Antibody Drug Conjugate Program
|
|
14 May 2020 |
Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome
|
|
14 May 2020 |
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA...
|
|
13 May 2020 |
Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
|
|
12 May 2020 |
Neurocrine Biosciences exercises option to license Idorsia's novel treatment for rare pediatric epilepsy
|
|
12 May 2020 |
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
|
|
08 May 2020 |
ACADIA Pharmaceuticals and Vanderbilt University Announce Exclusive License Agreement and Research Collaboration
|
|
07 May 2020 |
PTC Therapeutics to Acquire Censa Pharmaceuticals
|
|
07 May 2020 |
Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies
|
|
06 May 2020 |
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
|
|
06 May 2020 |
Magenta Therapeutics and AVROBIO Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
|
|
06 May 2020 |
Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University
|
|
05 May 2020 |
Alexion to Acquire Portola
|
|
04 May 2020 |
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
|
|
04 May 2020 |
Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
|
|
04 May 2020 |
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
|
